Related Experiment Video
Updated: Jan 19, 2026
Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
Published on: January 12, 2024
Zebrafish developmental toxicity assay: A fishy solution to reproductive toxicity screening, or just a red herring?
Kathleen Van den Bulck1, Adrian Hill, Natalie Mesens
1Drug Safety Sciences, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium. kvdbulck@its.jnj.com
Abstract:
The zebrafish embryotoxicity/teratogenicity assay is described as a useful alternative screening model to evaluate the effect of drugs on embryofoetal development. Fertilized eggs were exposed to different concentrations of 15 compounds with teratogenic (8) and non-teratogenic (7) potential until 96h post-fertilization when 28 morphological endpoints and the level of compound uptake was assessed. The majority of drugs testing positive in mammals was also positive in zebrafish (75% sensitivity), while a relative high number of false positives were noted (43% specificity). Compound uptake determination appears useful for clarifying classifications as teratogenic or potential overdose although assay sensitivity could be improved to 71% if the exposure threshold, previously suggested as ∼50ng/larvae, is reconsidered. The zebrafish assay shows some potential, though limited in its current form, as a screening tool for developmental toxicity within Janssen drug development. Further assay refinement with respect to endpoints and body burden threshold is required.
Insights
The zebrafish embryotoxicity assay shows potential for screening drug developmental toxicity. While it identified most teratogenic drugs, further refinement is needed to improve accuracy and reduce false positives.
Area of Science:
- Toxicology
- Developmental Biology
- Pharmacology
Background:
- Assessing drug effects on embryofoetal development is crucial.
- Existing methods can be time-consuming and ethically challenging.
- Alternative screening models are needed for efficient drug evaluation.
Purpose of the Study:
- To evaluate the zebrafish embryotoxicity/teratogenicity assay as an alternative screening model.
- To assess the assay's ability to predict developmental toxicity of known compounds.
- To identify areas for improvement in the zebrafish assay.
Main Methods:
- Zebrafish embryos were exposed to 15 compounds (8 teratogenic, 7 non-teratogenic) up to 96 hours post-fertilization.
- 28 morphological endpoints were assessed.
- Compound uptake (body burden) was measured in larvae.
Main Results:
- The assay demonstrated 75% sensitivity in identifying compounds teratogenic in mammals.
- A specificity of 43% was observed, with a notable number of false positives.
- Compound uptake analysis aided in classifying teratogenicity and potential overdose.
Conclusions:
- The zebrafish assay has potential as a screening tool for developmental toxicity in drug development.
- Assay sensitivity could be improved by reconsidering the exposure threshold.
- Further refinement of endpoints and body burden thresholds is necessary for enhanced utility.
Related Concept Videos
02:52Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae
06:25Evaluating Toxicity of Chemicals using a Zebrafish Vibration Startle Response Screening System
10:49Measuring RAN Peptide Toxicity in C. elegans
07:49Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos
07:08Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
17:28Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation